BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15474044)

  • 41. Functional differences of a Kv2.1 channel and a Kv2.1/Kv1.2S4-chimera are confined to a concerted voltage shift of various gating parameters.
    Koopmann R; Benndorf K; Lorra C; Pongs O
    Recept Channels; 1997; 5(1):15-28. PubMed ID: 9272573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proton and zinc effects on HERG currents.
    Anumonwo JM; Horta J; Delmar M; Taffet SM; Jalife J
    Biophys J; 1999 Jul; 77(1):282-98. PubMed ID: 10388757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of lanthanum on voltage-dependent gating of a cloned mammalian neuronal potassium channel.
    Tytgat J; Daenens P
    Brain Res; 1997 Feb; 749(2):232-7. PubMed ID: 9138723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three novel KCNA1 mutations in episodic ataxia type I families.
    Scheffer H; Brunt ER; Mol GJ; van der Vlies P; Stulp RP; Verlind E; Mantel G; Averyanov YN; Hofstra RM; Buys CH
    Hum Genet; 1998 Apr; 102(4):464-6. PubMed ID: 9600245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quercetin activates human Kv1.5 channels by a residue I502 in the S6 segment.
    Yang L; Ma JH; Zhang PH; Zou AR; Tu DN
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):154-61. PubMed ID: 18986330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of three episodic ataxia mutations in the human Kv1.1 potassium channel.
    Zerr P; Adelman JP; Maylie J
    FEBS Lett; 1998 Jul; 431(3):461-4. PubMed ID: 9714564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in
    Imbrici P; Accogli A; Blunck R; Altamura C; Iacomino M; D'adamo MC; Allegri A; Pedemonte M; Brolatti N; Vari S; Cataldi M; Capra V; Gustincich S; Zara F; Desaphy JF; Fiorillo C
    Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33466780
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein tyrosine kinase inhibitor genistein.
    Zhang ZH; Wang Q
    Pflugers Arch; 2000 Sep; 440(5):784-92. PubMed ID: 11007322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Episodic ataxias 1 and 2.
    Baloh RW
    Handb Clin Neurol; 2012; 103():595-602. PubMed ID: 21827920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Voltage-independent gating transitions in squid axon potassium channels.
    Spires S; Begenisich T
    Biophys J; 1995 Feb; 68(2):491-500. PubMed ID: 7696502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Cd2+ on Kv4.2 and Kv1.4 expressed in Xenopus oocytes and on the transient outward currents in rat and rabbit ventricular myocytes.
    Wickenden AD; Tsushima RG; Losito VA; Kaprielian R; Backx PH
    Cell Physiol Biochem; 1999; 9(1):11-28. PubMed ID: 10352341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Episodic ataxia type 1 and 2 (familial periodic ataxia/vertigo).
    Brandt T; Strupp M
    Audiol Neurootol; 1997; 2(6):373-83. PubMed ID: 9390841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of propofol with voltage-gated human Kv1.5 channel through specific amino acids within the pore region.
    Kojima A; Ito Y; Ding WG; Kitagawa H; Matsuura H
    Eur J Pharmacol; 2015 Oct; 764():622-632. PubMed ID: 26256861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular determinants of the inhibition of human Kv1.5 potassium currents by external protons and Zn(2+).
    Kehl SJ; Eduljee C; Kwan DC; Zhang S; Fedida D
    J Physiol; 2002 May; 541(Pt 1):9-24. PubMed ID: 12015417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Voltage-insensitive gating after charge-neutralizing mutations in the S4 segment of Shaker channels.
    Bao H; Hakeem A; Henteleff M; Starkus JG; Rayner MD
    J Gen Physiol; 1999 Jan; 113(1):139-51. PubMed ID: 9874694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Voltage sensitivity and gating charge in Shaker and Shab family potassium channels.
    Islas LD; Sigworth FJ
    J Gen Physiol; 1999 Nov; 114(5):723-42. PubMed ID: 10539976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetics of familial episodic vertigo and ataxia.
    Baloh RW; Jen JC
    Ann N Y Acad Sci; 2002 Apr; 956():338-45. PubMed ID: 11960817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of charybdotoxin on K+ channel (KV1.2) deactivation and inactivation kinetics.
    Sprunger LK; Stewig NJ; O'Grady SM
    Eur J Pharmacol; 1996 Oct; 314(3):357-64. PubMed ID: 8957259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular cloning and functional expression of a novel potassium channel beta-subunit from human atrium.
    Majumder K; De Biasi M; Wang Z; Wible BA
    FEBS Lett; 1995 Mar; 361(1):13-6. PubMed ID: 7890032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Separable effects of human Kvbeta1.2 N- and C-termini on inactivation and expression of human Kv1.4.
    Accili EA; Kuryshev YA; Wible BA; Brown AM
    J Physiol; 1998 Oct; 512 ( Pt 2)(Pt 2):325-36. PubMed ID: 9763623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.